Interacting Drugs |
Lidocaine (topical) vs Pimecrolimus Pimecrolimus |
Security Level |
|
Mechanism |
Pimecrolimus: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of Pimecrolimus. |
Management |
Monitor therapy |
Lidocaine (topical) vs Pimecrolimus
Post Review about Lidocaine (topical) vs Pimecrolimus Click here to cancel reply.
Other Interactions of Lidocaine (topical)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.